Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma

NCT01313884 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class

Stopped Study did not reach primary objective; study did not accrue enough patients.

Conditions

Interventions

Sponsor

Stanford University

Collaborators